Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
NCT00002493 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2014-02-14
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which treatment regimen is more effective for endometrial cancer.
PURPOSE: Randomized phase III trial to compare radiation therapy with chemotherapy in treating patients who have advanced endometrial cancer.
Conditions
- Endometrial Cancer
- Psychosocial Effects of Cancer and Its Treatment
Interventions
- DRUG
- DRUG
-
doxorubicin hydrochloride
- RADIATION
-
low-LET photon therapy
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Gynecologic Oncology Group
lead NETWORK
Principal Investigators
-
Marcus E. Randall, MD · Indiana University Melvin and Bren Simon Cancer Center
Study Design
- Purpose
- TREATMENT
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1992-05-31
- Primary Completion
- 2001-04-30
Countries
- United States
Study Locations
More Related Trials
-
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
NCT00492778 ·Status: UNKNOWN ·Phase: PHASE2
-
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
NCT00807768 ·Status: UNKNOWN ·Phase: PHASE3
-
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer
NCT01041027 ·Status: TERMINATED ·Phase: PHASE2
-
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
NCT00942357 ·Status: UNKNOWN ·Phase: PHASE3
-
Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
NCT00002993 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
NCT05691010 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Phase II Trial of Adjuvant Radiotherapy Combined With Chemotherapy for Patients With High-risk Endometrial Cancer
NCT01918124 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer
NCT00066456 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer
NCT00411138 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer
NCT01005329 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
NCT00003691 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer
NCT01461746 ·Status: UNKNOWN ·Phase: PHASE2
-
Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery
NCT00448643 ·Status: COMPLETED ·Phase: PHASE1
-
Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer
NCT00575952 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
NCT00016341 ·Status: TERMINATED ·Phase: PHASE3
-
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis
NCT00002949 ·Status: COMPLETED ·Phase: PHASE1
-
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
NCT03422198 ·Status: RECRUITING ·Phase: PHASE3
-
A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation
NCT00285415 ·Status: TERMINATED ·Phase: PHASE2
-
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
NCT05819892 ·Status: RECRUITING ·Phase: PHASE1
-
Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT02312245 ·Status: COMPLETED ·Phase: PHASE2
-
Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
NCT00071929 ·Status: COMPLETED ·Phase: PHASE2
-
Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer
NCT00542490 ·Status: COMPLETED ·Phase: PHASE2
-
Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
NCT00331760 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer
NCT02112552 ·Status: TERMINATED ·Phase: PHASE2
-
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
NCT03968406 ·Status: RECRUITING ·Phase: PHASE1